Trial Profile
Phase I Study Photodynamic Therapy Using Lutrin (Lutetium Texaphyrin) in the Treatment of Patients With Cervical Intraepithelial Neoplasia
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 13 Feb 2013
Price :
$35
*
At a glance
- Drugs Motexafin lutetium (Primary)
- Indications Cervical cancer
- Focus Adverse reactions
- 06 Feb 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 29 Sep 2005 New trial record.